{"name":"ElsaLys Biotech","slug":"elsalys-biotech","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Inolimomab (Leukotac)","genericName":"Inolimomab (Leukotac)","slug":"inolimomab-leukotac","indication":"Graft-versus-host disease (GVHD)","status":"phase_3"}]}],"pipeline":[{"name":"Inolimomab (Leukotac)","genericName":"Inolimomab (Leukotac)","slug":"inolimomab-leukotac","phase":"phase_3","mechanism":"Inolimomab is a monoclonal antibody that blocks the IL-2 receptor alpha chain (CD25) on T cells to suppress excessive immune activation.","indications":["Graft-versus-host disease (GVHD)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxQb09CNFpKRFpJNHZZdHJtNXp2SkgwS1NPUEV1WjBKLW43Mk5nNEdwc3dmNGlWYkxKN0tSdTJxXzRuWDhWS1VMY0RYak9WbjQyOUtLcUlJOHRIWkhFZFcxTDRheVhWX0ZHUUVwUktScGJiSDQyUE1Wb1M3NzByQ2Y4OXNsV2NoOS04aFNRRFRHekc3ejFDUGNOR3dVLUJ4QngzS3hIM1hsZUtTY2lYMVBwSS1KcHIyNkZfWjktTjJfTHI0OHJMRlNiaGFTUmxibVZid0pZS0lnbUlCOHRtWmRxU2Q0Y0JNbnBkTndGTkMxTG9LSFR1aHVRMkEySFBtWVNGR1FNWjYwMA?oc=5","date":"2020-05-07","type":"deal","source":"PR Newswire","summary":"Mediolanum Farmaceutici Acquires the French Company ElsaLys Biotech to Develop Next Generation Immuno-oncology Therapies - PR Newswire","headline":"Mediolanum Farmaceutici Acquires the French Company ElsaLys Biotech to Develop Next Generation Immuno-oncology Therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTFBkem9vSHlBTENBT2stMGFEcWNHVERaUkRnazUwdXBoV2RCVUI1c3d1ZndNTkZCUlowdU5CLUlZb3FCdkI1VnctOFlGZ0lYZVZHNGNVSE14cGJlajhqc25YcHk2QVhvMGtP?oc=5","date":"2020-05-07","type":"pipeline","source":"MedPage Today","summary":"Face-Aging Selfies Help Modify Risky Skin Behaviors for Teens - MedPage Today","headline":"Face-Aging Selfies Help Modify Risky Skin Behaviors for Teens","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2019-05-21","type":"pipeline","source":"openPR.com","summary":"Graft-Versus-Host Disease (GVHD) Market 2019: Competitor - openPR.com","headline":"Graft-Versus-Host Disease (GVHD) Market 2019: Competitor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE9iUVl4c3dEV1NSZ3htaFp6bjVyMzNDUkQ0d1V2RjBYTVdtdXVyY21ISG43cURZNklVZlJCU2k0aF9fU203cjZ4OXYtODBGbjNDdkFfVG9LaVo3R2Q4U1E?oc=5","date":"2019-05-03","type":"pipeline","source":"nature.com","summary":"People - nature.com","headline":"People","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}